J&J Focuses on Immunology with US$6.5 B Momenta Buyout
By Michelle Liu
Pharma Deals Review: Vol 2020 Issue 8 (Table of Contents)
Published: 24 Aug-2020
DOI: 10.3833/pdr.v2020.i8.2557 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In one of the largest M&A deals of 2020 so far, Johnson & Johnson (J&J) has agreed to acquire Momenta Pharmaceuticals for US$6...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS